SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. (ANNA) is trending due to its low float and position as a key natural gas supplier, with investors closely watching for a potential short squeeze amid rising European energy crisis concerns. The community is actively debating the stock's volatility and the impact of regional energy infrastructure reports, with many participants looking for momentum breakouts.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as market sentiment sours amid a confluence of geopolitical tensions, including concerns over the Strait of Hormuz, and negative news surrounding Elon Musk following a jury verdict related to business fraud allegations. The community is actively debating the stock's future as it breaks key technical support levels, with many traders questioning the company's valuation and delivery timelines for its AI and robotics initiatives while others speculate on potential capitulation points for a long-term rebound.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing renewed community activity driven by ongoing speculation regarding potential supply cuts and whale movement shifting assets to cold wallets. Investors remain polarized, with long-term holders expressing bullish sentiment on the token's ecosystem while others dismiss it as a stagnant speculative play.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is experiencing extreme volatility and heavy sell-off pressure following serious allegations of export violations and ongoing legal concerns surrounding the co-founder, fueling heated community debate over whether the stock is a 'falling knife' or a deep-value opportunity. Traders are actively discussing the risks of holding a 2x leveraged ETF during such sharp declines, with many warning about the destructive impact of daily decay and potential for further reverse splits.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing high volatility as investors react to after-hours market manipulation concerns and conflicting signals regarding the Iran conflict. While some traders are attempting to front-run a potential de-escalation based on presidential commentary, the community remains deeply divided, with many debating whether this is a genuine bottom or merely a short-lived bull trap amid ongoing military deployments.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending sharply downward following the unsealing of a federal indictment charging a co-founder and several associates with a massive scheme to smuggle restricted AI technology to sanctioned entities in China. While the company itself was not named as a defendant, investors and community members are expressing deep concern over repeated governance failures, the potential for strained relationships with key suppliers like Nvidia, and the possibility of further regulatory crackdowns.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors rally around the upcoming launch of its Super App and anticipation for institutional partnerships, specifically within the Stellar and Ripple ecosystems. The community is actively debating the project's long-term utility versus short-term price volatility, with many users focused on accumulating tokens ahead of these potential catalysts.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is currently at the center of investor anxiety as soaring oil prices and the escalating Middle East conflict fuel concerns over prolonged inflationary pressure and a potential bond market sell-off. The community is actively debating whether these geopolitical shocks will force a recessionary trade or if persistent supply-side inflation will break the Fed's ability to cut rates.

ETF Opportunities Trust - T-Rex 2X Long MSTR Daily Target ETF

T-Rex 2X Long MSTR Daily Target ETF

Community sentiment remains polarized as traders weigh the risks of extreme volatility and potential reverse splits in this leveraged crypto-linked fund against the long-term conviction of those betting on a recovery in Bitcoin-related equities. The primary catalyst driving the conversation is the aggressive institutional accumulation of Bitcoin by MicroStrategy, which has sparked intense debate over whether current price levels represent a bottom or a precursor to further deleveraging.

Guggenheim Strategic Opportunities Fund operates as a diversified, closed-end management investment company. The fund intends to maximize total return through a combination of current income and capital appreciation. It pursues a relative value-based investment philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate from their perceived fair value and/or historical norms. The company was founded on November 13, 2006 and is headquartered in Chicago, IL.

Guggenheim Strategic Opportunities Fund

Guggenheim Strategic Opportunities Fund (GOF) is trending as investors debate the sustainability of its high monthly distribution and the impact of share dilution, even as many community members continue to lean into the fund's monthly payouts and discounted dividend reinvestment programs. Sentiment remains polarized between those viewing current market volatility as a strategic accumulation opportunity and others cautioning against the fund's premium to Net Asset Value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus

ALLO, SBUX and AMGN highlight how Zacks strategies and portfolio picks are delivering strong gains despite recent market volatility.

Intellia Therapeutics (NASDAQ:NTLA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Intellia Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Hold" by Brokerages

Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Get Free Report) have received an average recommendation of "Hold" from the twenty-one analysts that are presently covering the stock, Marketbeat...

ARK Investment Management LLC Trims Stake in Intellia Therapeutics, Inc. $NTLA

ARK Investment Management LLC lessened its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 8.4% in the third quarter, according to the company in its most recent filing with...

Intellia Therapeutics (NASDAQ:NTLA) Upgraded at JonesTrading

JonesTrading raised Intellia Therapeutics from a "hold" rating to a "buy" rating and set a $29.00 price objective for the company in a research report on Wednesday...

Intellia Therapeutics (NASDAQ:NTLA) Given New $48.00 Price Target at Canaccord Genuity Group

Canaccord Genuity Group cut their price objective on shares of Intellia Therapeutics from $54.00 to $48.00 and set a "buy" rating on the stock in a research report on Tuesday...

Leerink Partners Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Leerink Partners lifted their price target on shares of Intellia Therapeutics from $27.00 to $29.00 and gave the company an "outperform" rating in a research note on Tuesday...

Royal Bank Of Canada Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Royal Bank Of Canada lifted their price target on shares of Intellia Therapeutics from $9.00 to $15.00 and gave the company a "sector perform" rating in a research report on Tuesday...

Wells Fargo & Company Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Wells Fargo & Company increased their target price on Intellia Therapeutics from $12.00 to $15.00 and gave the stock an "equal weight" rating in a research report on Tuesday...

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Key PointsArk Invest bought shares of MercadoLibre, Intellia Therapeutics, and Generate Biomedicines on Monday...

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.91	--	--	N/A
Q4 '25	-$0.94	-$0.83	11.81%	BEAT
Q3 '25	-$1.01	-$0.92	8.50%	BEAT
Q2 '25	-$1.02	-$0.98	3.70%	BEAT
Q1 '25	-$1.28	-$1.10	14.00%	BEAT

NTLA
Intellia Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest NTLA News

NTLAIntellia Therapeutics Inc